Occuity has been awarded a grant of £33,910 from the Berkshire Business Capital Grant Fund to support the manufacturing of the first product in our line of non-invasive optical screening and monitoring devices, the PM1 Pachymeter.
The grant is funded by The Berkshire LEP’s Getting Building Fund and will be used to support Occuity’s purchase of equipment needed to assemble test stations that will allow an increased capacity and more efficient quality control in the manufacturing of the world’s first non-contacting optical pachymeter, the PM1.
"Occuity demonstrated themselves as an innovative organisation in the life sciences and health sector, and we’re looking forward to seeing increased productivity and job creation within the organisation." Alison Webster - Chief Executive of The Berkshire LEP
This funding will support the creation of 15 extra jobs: ranging from engineers, salespeople, regulatory experts, and a new Head of Operations.
CEO and Co-founder Dr Dan Daly commented: “I am delighted that Occuity has received the support of Berkshire Business Capital Grant Fund. The grant will allow us to develop seven dedicated test stations, which will help us to identify faults early in significantly enhancing our production process. This will positively impact revenue generation and the business’ ability to grow profitably.
Daly continued, "Since we were founded in 2019, we’ve grown rapidly, and this funding will not only help us bring our first product to market but to continue creating new job opportunities in the Thames Valley Berkshire area and secure the longer-term future for our employees.”
Alison Webster, Chief Executive of The Berkshire LEP, said: “The investment from the Getting Building Fund to Occuity demonstrates the LEP’s commitment to high growth businesses in Berkshire looking to expand. Occuity demonstrated themselves as an innovative organisation in the life sciences and health sector, and we’re looking forward to seeing increased productivity and job creation within the organisation.”
To discover the Occuity PM1 and the rest of our innovative product pipeline, check out our website here
Comentarios